Ardsley Advisory Partners’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
KCM
Ardsley Advisory Partners's ABEO Position: Q4 2020 in Review
Ardsley Advisory Partners sold out of Abeona Therapeutics (ABEO) in Q4 2020, closing a stake of 1,000 shares — an estimated $26K sold.
Ardsley Advisory Partners first reported a position in ABEO in Q3 2016 and held it in 17 quarters. The position peaked at $853K in Q3 2017. 73 funds tracked by Wall St. Rank hold ABEO as of Q4 2020.
- Ardsley Advisory Partners reported no remaining Abeona Therapeutics position as of Q4 2020 after selling out during the quarter.
- Ardsley Advisory Partners sold 1,000 Abeona Therapeutics shares in Q4 2020, an estimated $26K.
- Ardsley Advisory Partners first reported a position in Abeona Therapeutics in Q3 2016 and held it in 17 quarters.
- Ardsley Advisory Partners's Abeona Therapeutics position peaked at $853K in Q3 2017.
- 73 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2020.
Based on Ardsley Advisory Partners's 13F filing for Q4 2020, filed 16 Feb 2021.